Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's Transformation FRONT ONCOL
Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries SCI REP-UK
A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results LEUKEMIA LYMPHOMA
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study LANCET ONCOL
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics EUR J HAEMATOL
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation BRIT J HAEMATOL